Quetiapine treatment in patients with Tourette syndrome [4]

Canadian Journal of Psychiatry

Volumn 46, Issue 2, 2001, Pages 184-185

  Parraga H C ^a   Parraga M I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CLOZAPINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN 2A RECEPTOR; SEROTONIN ANTAGONIST; SERTINDOLE; ZIPRASIDONE; ZOTEPINE;

CARDIOVASCULAR EFFECT; CHILD; DYSPHORIA; EXTRAPYRAMIDAL SYMPTOM; GILLES DE LA TOURETTE SYNDROME; HUMAN; LETTER; MOTOR DYSFUNCTION; TIC;

EID: 0035066213     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370104600220     Document Type: Letter

References (9)

1. Haloperidol induced dysphoria in patientes with Tourette's Syndrome
2. Case study: Adverse response to clonidine
3. The trial use of clozapine for abnormal involuntary movement disorders
4. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report
5. Olanzapine in Gilles de la Tourette syndrome patients
6. Ziprasidone treatment of children and adolescents with Tourette's Syndrome: A pilot study
7. Receptor pharmacology of neuroleptics: Relation to clinical effects
8. Preclinical pharmacology of atypical antipsychotic drugs
9. Premedication influenced D2 receptor occupancy with quetiapine and sertindole